| Today's Big NewsMar 13, 2023 |
|
April 3 - 4, 2023 | San Diego, CA This event will focus on how to wear multiple hats in a communications role and how to work with stakeholders to succeed. Register Today!
|
|
| By Max Bayer President Joe Biden looked to assure Americans that the banking system was safe after U.S. regulators announced they'd backup all depositors of Silicon Valley Bank. The move comes days after a $42 billion bank run tanked the once-heralded startup and biotech financier. |
|
|
|
By James Waldron The U.K.'s BioIndustry Association has praised the government for securing a buyer for the U.K. subsidiary of the failed Silicon Valley Bank. |
By Annalee Armstrong,Max Bayer,Gabrielle Masson Silicon Valley Bank’s capital raise of $2 billion has sent shock waves across the biotech industry and spurred a panic among some top venture capital firms that are urging their companies to withdraw deposits. |
Sponsored by Thermo Fisher Scientific In the development of mRNA vaccines and therapeutics, identifying a raw materials supplier who can partner with you from preclinical to commercial supply is a key to success. |
By James Waldron An antibody-drug conjugate that GSK paid $100 million to license from Mersana Therapeutics has been slapped with a clinical hold after a patient died in the therapy’s first trial. |
By Helen Floersh Projects by teams from Stanford University and Johns Hopkins University will be part of the payload March 14 on SpaceX CRX-27, a resupply mission to the International Space Station. The researchers hope to leverage aging effects of microgravity on heart muscle cells to ultimately help identify new treatments for cardiovascular disease. |
By Fraiser Kansteiner After Sanofi lost the bidding war for Horizon Therapeutics in December, the question wasn’t so much if the French pharma would pursue another buyout, but when. |
By Kevin Dunleavy Scoring two of the three largest M&A deals in biopharma last year was just an appetizer for Pfizer. On Monday, the industry giant sat down to the main course, gobbling up Seattle cancer specialist Seagen for $43 billion. It is the largest acquisition in biopharma since June of 2019, when AbbVie acquired Allergan for $63 billion. |
By Andrea Park A study published in the journal Respiratory Care this month found that University of Cincinnati startup PEP Buddy’s eponymous device significantly improved COPD patients’ breathlessness caused by physical activity. |
By Zoey Becker Doctors and scientists have been studying Rett syndrome for decades, but up until now, there have been no approved treatments. Enter Acadia's Daybue. |
By Robert King CMMI is taking political heat from congressional Republicans over a proposed payment model that seeks to lower Medicare payments to drugs granted accelerated approval by the FDA. |
By Fraiser Kansteiner,Eric Sagonowsky,Zoey Becker,Kevin Dunleavy,Angus Liu The Fierce Pharma team didn't want AbbVie's Humira to have the entire patent-cliff spotlight this year, so we're presenting this special report on the top U.S. losses of exclusivity in 2023. Besides Humira, drugs from J&J, AstraZeneca and more make the list. |
Fierce podcastsDon't miss an episode |
| | This week on "The Top Line," we take on AI and machine learning in the pharma and healthcare universe. The expectation is that these tools will speed up innovation and open up new markets, helping the sector stay ahead of the curve. Plus, this week's headlines. |
|
|---|
|
|
|
May 1 - 3, 2023 | Jersey City, NJ Connect with senior executives in Medical Affairs, MSL and IIT to share best practices. Save $200 when you register today!
|
|
| Whitepaper Preparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
| Executive SummaryRead about the latest survey results from over 200 biopharma executives and the changing approaches to building biologic drug development pipelines. Sponsored by: Twist Bioscience |
| WhitepaperHave you had your questions about mRNA/saRNA manufacturing unanswered during a webinar; have no fear, we have you covered here. Sponsored by: Aldevron |
| Whitepaper Download Herspiegel Consulting’s Go-To-Market Model, based on 100+ launches, to learn the critical components, and timelines for commercial success. Sponsored by: Herspiegel Consulting |
| ResearchLike many top 10 and global pharma companies, an H1 client needed to diversify both its patient outreach and site investigator profiles for upcoming trials. Sponsored by: H1 |
| Whitepaper Discover the Power of Small with NanoplasmidTM – the next-generation plasmid for manufacturing today’s cell and gene therapies. Sponsored by: Aldevron |
| WhitepaperLearn more about critical success factors for your next launch based on the experience of 100+ pharma product launches. Sponsored by: Herspiegel Consulting |
| WhitepaperWhat are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored By: Catalent |
| Research Learn more on Catalent’s step-wise approach for the definition and execution of Process Characterization for the production of a monoclonal antibody for late phase process characterization and development. Sponsored by: Catalent |
| WhitepaperExplore how clinical supply can be scaled up as decentralized programs progress, and how technological solutions can accelerate trial deployment. Sponsored by: Catalent Clinical Supply |
| Whitepaper As sponsors increasingly look to CROs to support their clinical studies, making and addressing certain clinical supply considerations at the outset of the relationship can reduce the risk of potentially unforeseen impact to budget and time later. Discover key issues sponsors should consider to help their CRO or partner of choice better understand their clinical supply needs. Sponsored by: Catalent |
| WhitepaperFor sponsors, cost is a key concern when it comes to managing the supply of their clinical trials. A financial project analyst (FPA) is a specialized expert who can help control clinical supply costs and keep the project within budget. Explore the critical role that a Financial Project Analyst plays in clinical trial supply and budget management. Sponsored by: Catalent |
| WhitepaperLearn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
| WhitepaperDiscover key considerations that every trial sponsor should know when navigating the complex clinical supply distribution landscape across Asia-Pacific. Sponsored by: Catalent |
| WhitepaperHow can specialized expertise help you optimize your clinical supply chain? Learn about the roles and responsibilities of unique experts such as clinical supply management, project management, and financial project analysis. Sponsored by: Catalent Clinical Supply |
| Research Learn more on an approach for process characterization for the production of a monoclonal antibody, which will improve the efficiency and effectiveness of the process by targeting the right design and number of experiments. Sponsored by: Catalent |
| WhitepaperExplore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
| WhitepaperPlanning on using a CRO to support your next clinical study? This infographic outlines critical areas to address at the start of the relationship in order to ensure that budget and timelines keep on track for the duration of the trial. Sponsored by: Catalent |
| Case Study Learn more on an approach for process characterization for the production of a monoclonal antibody, which will improve the efficiency and effectiveness of the process by targeting the right design and number of experiments. Sponsored by: Catalent |
| |
|
